Published on 16 December 2014
Biosimilars for prescribers
Author(s): Adjunct Professor Pekka Kurki, MD, PhD
biosimilars, comparability, interchangeability, prescribers, regulators
DOI: 10.5639/gabij.2015.0401.008
12.543 views
Published on 16 December 2014
Author(s): Adjunct Professor Pekka Kurki, MD, PhD
biosimilars, comparability, interchangeability, prescribers, regulators
DOI: 10.5639/gabij.2015.0401.008
12.543 views
Published on 16 December 2014
Author(s): European Biopharmaceutical Enterprises
biological medicines, biosimilars, off-patent market, pricing and reimbursement policy
DOI: 10.5639/gabij.2015.0401.006
22.323 views
Published on 16 December 2014
Author(s): Debra Hoppensteadt, PhD, Jawed Fareed, PhD, Jeanine M Walenga, PhD, Josephine Cunanan, MD, Mamdouh Bakhos, MD, Nicolas Simon, MD, PhD, Vicki Escalante, BS, Professor Walter P Jeske, PhD
anticoagulation, generics, heparins, pharmacodynamics, pharmacokinetics, population
DOI: 10.5639/gabij.2015.0402.016
32.293 views
Published on 16 December 2014
Author(s): André Vidal Pinheiro, PhD, Associate Professor Valderilio Feijó Azevedo, MD, PhD, MSc, Daniele Severi Bruni, MPhil, Ronald Halbert, MD, MPH, Erik Sandorff, MA, MBA
biosimilar pharmaceuticals, discounts, drug industry, Latin America, prescribing
DOI: 10.5639/gabij.2015.0401.005
10.236 views
Published on 16 December 2014
Author(s): Barbara J van Zwieten-Boot, Marcel Hoefnagel, Peter MJM Jongen, R Martijn van der Plas
active substance, biosimilar, EMA, Europe, guidelines, regulatory
DOI: 10.5639/gabij.2015.0401.004
11.261 views
Published on 15 December 2014
Author(s): Brian Godman, BSc, PhD
Europe, generics, hospitals, procurement
DOI: 10.5639/gabij.2014.0304.037
9.229 views
Published on 12 December 2014
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2014.0304.048
6.579 views
Published on 01 December 2014
Author(s): David Lim, DPH
Australia, biosimilars, confidential information, patent, regulation, remuneration
DOI: 10.5639/gabij.2014.0304.042
9.831 views
Published on 01 December 2014
Author(s): GaBI Journal Editor
DOI: 10.5639/gabij.2014.0304.046
7.518 views
Published on 28 November 2014
Author(s): René Anour, DVM
biobetter, biosimilar, competition, interchangeability, regulatory pathways
DOI: 10.5639/gabij.2014.0304.039
124.186 views
Published on 04 November 2014
3.341 views
Published on 22 October 2014
3.169 views